Teladoc Health (BSP:T2DH34) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:T2DH34 Teladoc Health Inc BSP:T2DH34
57 GF Score
Price R$33.21
GF Value R$40.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Teladoc Health Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Teladoc Health  (BSP:T2DH34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Teladoc Health Cyclically Adjusted PS Ratio Related Terms


Teladoc Health Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Teladoc Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teladoc Health Cyclically Adjusted PS Ratio Chart

Teladoc Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.78 3.94 2.04 1.44

Teladoc Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 1.24 1.17 0.81 1.31

BSP:T2DH34 vs GDRX, CERT, OMDA: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, Teladoc Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teladoc Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teladoc Health's Cyclically Adjusted PS Ratio falls into.


BSP:T2DH34
57GF Score
Teladoc Health Inc BSP:T2DH34
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teladoc Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Teladoc Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Teladoc Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.565/333.9520*333.9520
=0.565

Current CPI (Jun. 2026) = 333.9520.

Teladoc Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.291 241.428 3.169
201612 2.676 241.432 3.701
201703 2.583 243.801 3.538
201706 2.626 244.955 3.580
201709 3.849 246.819 5.208
201712 4.291 246.524 5.813
201803 4.709 249.554 6.302
201806 5.410 251.989 7.170
201809 6.418 252.439 8.490
201812 6.653 251.233 8.844
201903 6.830 254.202 8.973
201906 7.120 256.143 9.283
201909 7.588 256.759 9.869
201912 8.876 256.974 11.535
202003 11.014 258.115 14.250
202006 16.931 257.797 21.933
202009 18.578 260.280 23.836
202012 16.129 260.474 20.679
202103 16.335 264.877 20.595
202106 17.092 271.696 21.008
202109 17.100 274.310 20.818
202112 19.356 278.802 23.185
202203 18.404 287.504 21.377
202206 18.066 296.311 20.361
202209 19.828 296.808 22.309
202212 0.689 296.797 0.775
202303 0.668 301.836 0.739
202306 0.656 305.109 0.718
202309 0.651 307.789 0.706
202312 0.657 306.746 0.715
202403 0.636 312.332 0.680
202406 0.655 314.175 0.696
202409 0.690 315.301 0.731
202412 0.721 315.605 0.763
202503 0.704 319.799 0.735
202506 0.679 322.561 0.703
202509 0.643 324.800 0.661
202512 0.649 324.054 0.669
202603 0.600 330.213 0.607
202606 0.565 333.952 0.565

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Teladoc Health (BSP:T2DH34) Overvalued in 2026?

Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued. The current stock price of R$33.21 is trading 18.4% below its estimated GF Value™ of R$40.72. GuruFocus considers Teladoc Health to be Modestly Undervalued.

Key valuation signals for BSP:T2DH34:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: R$40.72 vs. price of R$33.21 (18.4% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the BSP:T2DH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teladoc Health Business Description

Address 155 East 44th Street, Suite 1700, New York, NY, USA, 10017
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
57GF Score

Get the complete analysis for BSP:T2DH34

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$33.21
Price
R$40.72
GF Value